Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2011

Oct 31, 2011

29750_dirs_2011-10-31_b2ec8b0b-d163-4942-9311-5f418f1b6495.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2011-10-27

Reporting Person: COSGROVE STEPHEN J (Corporate Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-27 Common Stock M 1700 $57.30 Acquired 76636 Direct
2011-10-27 Common Stock F 1487 $65.50 Disposed 75149 Direct
2011-10-28 Common Stock M 28300 $57.30 Acquired 103449 Direct
2011-10-28 Common Stock S 26300 $65.45 Disposed 77149 Direct
2011-09-30 Common Stock J 50 Acquired 333 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-10-27 Employee Stock Options (Right to Buy) $57.30 M 1700 Disposed 2012-02-10 Common Stock (1700) Direct
2011-10-28 Employee Stock Option (Right to Buy) $57.30 M 28300 Disposed 2012-02-10 Common Stock (28300) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1594 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $65.41 to $65.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Shares acquired in the Johnson & Johnson Stock Fund under the Johnson & Johnson 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2011).

F3: Shares held by ESOP under the Johnson & Johnson 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2011).

F4: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.